Original paper
PRRT: Defining the Paradigm Shift to Achieve Standardization and Individualization
Abstract
Peptide receptor radionuclide therapy is a treatment for inoperable or metastatic neuroendocrine tumors. A key issue is the need to standardize the treatment and develop randomized controlled trials. Standardization would help define the characteristics of response, including progression-free survival; provide homogeneous phase II and III studies; delineate the position of peptide receptor radionuclide therapy in the therapeutic algorithm for...
Paper Details
Title
PRRT: Defining the Paradigm Shift to Achieve Standardization and Individualization
Published Date
Sep 25, 2014
Journal
Volume
55
Issue
11
Pages
1753 - 1756
Citation AnalysisPro
You’ll need to upgrade your plan to Pro
Looking to understand the true influence of a researcher’s work across journals & affiliations?
- Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
- Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.
Notes
History